Integrated Biopharma CFO Dina Masi's 2022 pay rises 12% to $300K

Integrated Biopharma reports 2022 executive compensation

By ExecPay News

Published: October 27, 2023

Integrated Biopharma reported fiscal year 2022 executive compensation information on October 27, 2023.
In 2022, five executives at Integrated Biopharma received on average a compensation package of $286K, a 12% increase compared to previous year.
Average pay of disclosed executives at Integrated Biopharma
Dina Masi, Chief Financial Officer, received $300K in total, which increased by 12% compared to 2021. 85% of Masi's compensation, or $254K, was in salary. Masi also received $37K in option awards and $9.6K in other compensation.
E. Gerald Kay, Chairman, received a compensation package of $286K. 75% of the compensation package, or $216K, was in salary.
E.Gerald Kay, Chairman, earned $286K in 2022, a 11% increase compared to previous year.
Riva Sheppard, Chief Executive Officer, received $278K in 2022, which increases by 14% compared to 2021.
Christina Kay, Chief Executive Officer, earned $276K in 2022, a 12% increase compared to previous year.
Integrated Biopharma's fiscal year ends on June 30.

Related executives

E Kay

Integrated Biopharma

Chairman

Christina Kay

Integrated Biopharma

Chief Executive Officer

Riva Sheppard

Integrated Biopharma

Chief Executive Officer

EGerald Kay

Integrated Biopharma

Chairman

Dina Masi

Integrated Biopharma

Chief Financial Officer

You may also like

Source: SEC filing on October 27, 2023.